BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/19/2021 11:47:26 AM | Browse: 49 | Download: 38
Publication Name World Journal of Gastroenterology
Manuscript ID 67389
Country/Territory United States
2021-04-23 00:57
Peer-Review Started
2021-04-23 00:59
To Make the First Decision
Return for Revision
2021-06-23 02:16
2021-07-09 04:25
Second Decision
2021-10-27 09:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-10-27 21:36
Articles in Press
2021-10-27 21:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-11-16 14:18
Publish the Manuscript Online
2021-11-19 11:15
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
Manuscript Source Invited Manuscript
All Author List Mina S Makary, Stuart Ramsell, Eric Miller, Eliza W Beal and Joshua D Dowell
Funding Agency and Grant Number
Corresponding Author Mina S Makary, MD, Assistant Professor, Attending Doctor, Director, Department of Radiology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, 4th Floor, Columbus, OH 43210, United States. mina.makary@osumc.edu
Key Words Hepatocellular carcinoma; Bland embolization; Chemoembolization; Radioembolization; Transarterial embolization; Thermal ablation; Locoregional therapy
Core Tip This article reviews prognostic factors and outcomes of current locoregional therapies for hepatocellular carcinoma, as well as future directions and promising new techniques. Therapies including transarterial bland embolization, chemoembolization, and radioembolization, as well as percutaneous ablation are reviewed. Prognostic considerations vary by indication but generally follow baseline disease staging and tumor quantification. Outcomes data reveal survival benefits in appropriately selected patients. New advances in precision medicine, combination therapy, and immunotherapy are being investigated.
Publish Date 2021-11-19 11:15
Citation Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479
URL https://www.wjgnet.com/1007-9327/full/v27/i43/7462.htm
DOI https://dx.doi.org/10.3748/wjg.v27.i43.7462
Full Article (PDF) WJG-27-7462.pdf
Full Article (Word) WJG-27-7462.docx
Manuscript File 67389_Auto_Edited.docx
Answering Reviewers 67389-Answering reviewers.pdf
Audio Core Tip 67389-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 67389-Conflict-of-interest statement.pdf
Copyright License Agreement 67389-Copyright license agreement.pdf
Peer-review Report 67389-Peer-review(s).pdf
Scientific Editor Work List 67389-Scientific editor work list.pdf